Botanical species · safety record

Consolida ajacis

The EFSA Compendium of Botanicals holds 11 constituent measurements for Consolida ajacis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Consolida ajacis (L.) Schur

11Constituent measurements
0Safety records
6Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Norditerpene alkaloids7
  • Ajacine1
  • Delcosine1
  • Gigactonine1
  • Takaosamine1

Plant parts

  • Seed6
  • Leaves3
  • Roots and other underground parts1
  • Stem1
  • stalk1

Preparations

  • Solvent extraction11

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AjacineSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
DelcosineSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
GigactonineSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Norditerpene alkaloidsSeedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Norditerpene alkaloidsStem / stalkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Norditerpene alkaloidsLeavesSolvent extraction0.0012 PercentNuclear Magnetic Resonance (NMR)Resolve DOI
Norditerpene alkaloidsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Norditerpene alkaloidsLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Norditerpene alkaloidsLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Norditerpene alkaloidsSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
TakaosamineSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. DESAI, HK., CARTWRIGHT, BT., PELLETIER, SW. AJADININE - A NEW NORDITERPENOID ALKALOID FROM THE SEEDS OF DELPHINIUM-AJACIS - THE COMPLETE NMR ASSIGNMENTS FOR SOME LYCOCTONINE-TYPE ALKALOIDS . Journal of natural products, 1994, vol. 57, no. 5, p. 677-682. DOI
  2. LIANG, XH., ROSS, SA., SOHNI, YR., SAYED, HM., DESAI, HK., JOSHI, BS., PELLETIER, SW. NORDITERPENOID ALKALOIDS FROM THE STEMS AND LEAVES OF DELPHINIUM-AJACIS. Journal of natural products, 1991, vol. 54, no. 5, p. 1283-1287. DOI
  3. Venkateswarlu, V., Srivastava, SK., Joshi, BS., Desai, HK., Pelletier, SW. 13-O-acetylvakhmatine, a new diterpenoid alkaloid from the seeds of Consolida ambigua . Journal of natural products, 1995, vol. 58, no. 10, p. 1527-1532. DOI
  4. JOSHI, BS., PUAR, MS., DESAI, HK., ROSS, SA., LU, J., PELLETIER, SW. THE STRUCTURE OF AJABICINE, A NOVEL DITERPENOID ALKALOID FROM DELPHINIUM-AJACIS . Tetrahedron letters, 1993, vol. 34, no. 9, p. 1441-1444. DOI
  5. PELLETIER, SW., BHANDARU, S., DESAI, HK., ROSS, SA., SAYED, HM. 2 NEW NORDITERPENOID ALKALOIDS FROM THE ROOTS OF DELPHINIUM-AJACIS. Journal of natural products, 1992, vol. 55, no. 6, p. 736-743. DOI
  6. LU, J., DESAI, HK., ROSS, SA., SAYED, HM., PELLETIER, SW. NEW NORDITERPENOID ALKALOIDS FROM THE LEAVES OF DELPHINIUM-AJACIS. Journal of natural products, 1993, vol. 56, no. 12, p. 2098-2103. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue